PACAP promotes neuron survival in early experimental diabetic retinopathy

Neurochemistry International

Volumn 64, Issue 1, 2014, Pages 84-91

  Szabadfi, Krisztina ^a   Szabo, Aliz ^b   Kiss, Peter ^a   Reglodi, Dora ^a   Setalo, Gyorgy ^b   Kovacs, Krisztina ^b   Tamas, Andrea ^a   Toth, Gabor ^c   Gabriel, Robert ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anti apoptotic factors; Caspases; Diabetic retinopathy; PACAP; TUNEL

Indexed keywords

CASPASE 12; CASPASE 3; CASPASE 8; GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; EYE PROTECTION; GLUCOSE BLOOD LEVEL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; RETINA; RETINA AMACRINE CELL; RETINA NERVE CELL; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

RATTUS;

ANTI-APOPTOTIC FACTORS; CASPASES; DIABETIC RETINOPATHY; ENDOPLASMATIC RETICULUM; ER; ERKS; EXTRACELLULAR SIGNAL-REGULATED KINASES; GANGLION CELL LAYER; GAPDH; GCL; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3 BETA; GSK3Β; INL; INNER NUCLEAR LAYER; INNER PLEXIFORM LAYER; IPL; MAPKS; MITOGEN ACTIVATED PROTEIN KINASES; ONL; OPL; OUTER NUCLEAR LAYER; OUTER PLEXIFORM LAYER; PAC1-R; PACAP; PACAP TYPE 1 RECEPTOR; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PKA; PKC; PROTEIN KINASE A; PROTEIN KINASE C; TERMINAL TRANSFERASE DUTP NICK END LABELING; TH; TUNEL; TYROSINE HYDROXYLASE; VASOACTIVE INTESTINAL PEPTIDE; VIP;

ANIMALS; APOPTOSIS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; MALE; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RETINA; STREPTOZOCIN;

EID: 84889076365     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.11.005     Document Type: Article

References (53)

1. A.M. Abu El-Asrar, L. Dralands, L. Missotten, I.A. Al-Jadaan, and K. Geboes Expression of apoptosis markers in the retinas of human subjects with diabetes Invest. Ophthalmol. Vis. Sci. 45 2004 2760 2766 (Pubitemid 38998875)
2. A.M. Abu El-Asrar, L. Dralands, L. Missotten, and K. Geboes Expression of antiapoptotic and proapoptotic molecules in diabetic retinas Eye (London) 21 2007 238 245 (Pubitemid 46454604)
3. T. Atlasz, K. Szabadfi, P. Kiss, B. Racz, F. Gallyas, A. Tamas, V. Gaal, Zs. Marton, R. Gabriel, and D. Reglodi Review of pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects Ann. N. Y. Acad. Sci. 1200 2010 128 139
4. E. Banki, P. Degrell, P. Kiss, K. Kovacs, A. Kemeny, K. Csanaky, A. Duh, D. Nagy, G. Toth, A. Tamas, and D. Reglodi Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy Peptides 42C 2013 125 130
5. A.J. Barber, E. Lieth, S.A. Khin, D.A. Antonetti, A.G. Buchanan, and T.W. Gardner Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J. Clin. Invest. 102 1998 783 791 (Pubitemid 28399611)
6. A. Castorina, S. Giunta, V. Mazzone, V. Cardile, and V. D'Agata Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells Peptides 31 12 2010 2276 2283
7. V. D'Agata, and S. Cavallaro Functional and molecular expression of PACAP/VIP receptors in the rat retina Brain Res. Mol. Brain Res. 54 1 1998 161 164 (Pubitemid 28119172)
8. A. Degterev, M. Boyce, and J. Yuan A decade of caspases Oncogene 22 2003 8543 8567 (Pubitemid 38028527)
9. T. Dickinson, R. Mitchell, P. Robberecht, and S.M. Fleetwood-Walker The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy Neuropharmacology 38 1999 167 180 (Pubitemid 29073536)
10. H. Dziema, and K. Obrietan PACAP potentiates L-type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway J. Neurophysiol. 88 2002 1374 1386 (Pubitemid 35025391)
11. R.L. Fleming, M.S. Silveira, L.E. Santos, I.P. Henze, P.F. Gardino, M.C. de Mello, and F.G. de Mello Pituitary adenylyl cyclase-activating polypeptide receptor re-sensitization induces plastic changes in the dopaminergic phenotype in the mature avian retina J. Neurochem. 124 5 2013 621 631
12. R.A. Frost, G.J. Nystrom, and C.H. Lang Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway Endocrinology 141 9 2000 3156 3164 (Pubitemid 32269003)
13. X.Y. Gao, H.Y. Kuang, W. Zou, X.M. Liu, H.B. Lin, and Y. Yang The timing of re-institution of good blood glucose control affects apoptosis and expression of Bax and Bcl-2 in the retina of diabetic rats Mol. Biol. Rep. 36 2009 1977 1982
14. M.J. Gastinger, R.S. Singh, and A.J. Barber Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas Invest. Ophthalmol. Vis. Sci. 47 2006 3143 3150 (Pubitemid 351639794)
15. S. Giunta, A. Castorina, C. Bucolo, G. Magro, F. Drago, and V. D'Agata Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats Peptides 37 2012 32 39
16. H.P. Hammes, H.J. Federoff, and M. Brownlee Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes Mol. Med. 1 1995 527 534
17. S. Izumi, T. Seki, S. Shioda, C.J. Zhou, A. Arimura, and R. Koide Ultrastructural localization of PACAP immunoreactivity in the rat retina Ann. N. Y. Acad. Sci. 921 2000 317 320 (Pubitemid 32094562)
18. K. Kannan, and S.K. Jain Oxidative stress and apoptosis Pathophysiology 7 2000 153 163
19. T.S. Kern, and A.J. Barber Retinal ganglion cells in diabetes J. Physiol. 15 2008 4401 4408
20. D. Landau, R. Eshet, A. Troib, Y. Gurman, Y. Chen, R. Rabkin, and Y. Segev Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation Endocrine 36 1 2009 126 134
21. P. Lazarovici, G. Cohen, H. Arien-Zakay, J. Chen, C. Zhang, M. Chopp, and H. Jiang Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models J. Mol. Neurosci. 48 2012 526 540
22. M. Li, C. David, T. Kikuta, A. Somogyvari-Vigh, and A. Arimura Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38 J. Mol. Neurosci. 27 2005 91 105
23. M. Li, J.L. Maderdrut, J.J. Lertora, A. Arimura, and V. Batuman Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases Regul. Pept. 145 2008 24 32 (Pubitemid 350296365)
24. C.L. Lin, J.Y. Wang, Y.T. Huang, Y.H. Kuo, K. Surendran, and F.S. Wang Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells J. Am. Soc. Nephrol. 17 10 2006 2812 2820 (Pubitemid 44484671)
25. P.M. Martin, P. Roon, T.K. Van Ells, V. Ganapathy, and S.B. Smith Death of retinal neurons in streptozotocin-induced diabetic mice Invest. Ophthalmol. Vis. Sci. 45 2004 3330 3336 (Pubitemid 39121873)
26. L. Mester, K. Kovacs, B. Racz, I. Solti, T. Atlasz, K. Szabadfi, A. Tamas, and D. Reglodi Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells J. Mol. Neurosci. 43 2011 35 43
27. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, B.A. Yankner, and J. Yuan Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta Nature 403 2000 98 103 (Pubitemid 30038529)
28. T. Nakamachi, A. Matkovits, T. Seki, and S. Shioda Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina Front. Endocrinol. (Lausanne) 3 2012 145
29. H. Ohtaki, T. Nakamachi, K. Dohi, and S. Shioda Role of PACAP in ischemic neural death J. Mol. Neurosci. 36 2008 16 25
30. M.S. Ola, M.I. Nawaz, M.M. Siddiquei, S. Al-Amro, and A.M. Abu El-Asrar Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy J. Diabetes Complications 26 2012 56 64
31. D. Pathak, A. Gupta, B. Kamble, G. Kuppusamy, and B. Suresh Oral targeting of protein kinase C receptor: promising route for diabetic retinopathy? Curr. Drug. Deliv. 9 4 2012 405 413
32. B. Racz, F. Gallyas Jr.; P. Kiss, G. Toth, O. Hegyi, B. Gasz, B. Borsiczky, A. Ferencz, E. Roth, A. Tamas, I. Lengvari, A. Lubics, and D. Reglodi The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways Regul. Pept. 137 2006 20 26 (Pubitemid 44781242)
33. B. Racz, B. Gasz, B. Borsiczky, F. Gallyas Jr.; A. Tamas, R. Jozsa, A. Lubics, P. Kiss, E. Roth, A. Ferencz, G. Toth, O. Hegyi, I. Wittmann, I. Lengvari, A. Somogyvari-Vigh, and D. Reglodi Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis Gen. Comp. Endocrinol. 153 2007 115 123 (Pubitemid 47103325)
34. D. Reglodi, P. Kiss, K. Szabadfi, T. Atlasz, R. Gabriel, G. Horvath, P. Szakaly, B. Sandor, A. Lubics, E. Laszlo, J. Farkas, A. Matkovits, R. Brubel, H. Hashimoto, A. Ferencz, A. Vincze, Z. Helyes, L. Welke, A. Lakatos, and A. Tamas PACAP is an endogenous protective factor-insights from PACAP-deficient mice J. Mol. Neurosci. 48 3 2012 482 492
35. S. Scuderi, A.G. D'Amico, A. Castorina, R. Imbesi, M.L. Carnazza, and V. D'Agata Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction Peptides 39 2013 119 124
36. T. Seaborn, O. Masmoudi-Kouli, A. Fournier, H. Vaudry, and D. Vaudry Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis Curr. Pharm. Des. 17 2011 204 214
37. T. Seki, S. Izumi, S. Shioda, C.J. Zhou, A. Arimura, and R. Koide Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR Ann. N. Y. Acad. Sci. 921 2000 366 369 (Pubitemid 32094571)
38. M. Seki, T. Tanaka, H. Nawa, T. Usui, T. Fukuchi, K. Ikeda, H. Abe, and N. Takei Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells Diabetes 53 2004 2412 2419 (Pubitemid 39145597)
39. S. Shioda, H. Ohtaki, T. Nakamachi, K. Dohi, J. Watanabe, S. Nakajo, S. Arata, S. Kitamura, H. Okuda, F. Takenoya, and Y. Kitamura Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment Ann. N. Y. Acad. Sci. 1070 2006 550 560 (Pubitemid 44126702)
40. A. Somogyvari-Vigh, J. Svoboda-Teet, S. Vigh, and A. Arimura Is an intravenous bolus injection required prior to initiating slow intravenous infusion of PACAP38 for prevention of neuronal death induced by global ischemia? The possible presence of a binding protein for PACAP38 in blood Ann. N. Y. Acad. Sci. 865 1998 595 600 (Pubitemid 29047892)
41. A. Somogyvari-Vigh, and D. Reglodi Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide Review Curr. Pharm. Des. 10 2004 2861 2889 (Pubitemid 39172068)
42. K. Szabadfi, T. Atlasz, P. Kiss, D. Reglodi, A. Szabo, K. Kovacs, B. Szalontai, Gy. Setalo Jr.; E. Banki, K. Csanaky, A. Tamas, and R. Gabriel Protective effects of the neuropeptide PACAP in diabetic retinopathy Cell Tissue Res. 348 2012 37 46
43. K. Szabadfi, T. Atlasz, P. Kiss, B. Danyadi, A. Tamas, Z. Helyes, H. Hashimoto, N. Shintani, A. Baba, G. Toth, R. Gabriel, and D. Reglodi Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo Neurotox. Res. 21 2012 41 48
44. K. Szabadfi, P. Kiss, D. Reglodi, A. Szabo, B. Szalontai, K. Kovacs, Gy. Setalo Jr.; E. Banki, K. Csanaky, A. Tamas, S. Shioda, T. Atlasz, and R. Gabriel Ameliorative potential of pituitary adenylate cyclase activating polypeptide in streptozotocin-induced diabetic retinopathy in rats J. Neurochem. 125 Suppl. 1 2013 146 147
45. A. Szabo, B. Danyadi, E. Bognar, K. Szabadfi, E. Fabian, P. Kiss, L. Mester, M. Sridharan, T. Atlasz, R. Gabriel, G. Toth, A. Tamas, D. Reglodi, and K. Kovacs Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion Neurosci. Lett. 523 2012 93 98
46. A. Tamas, R. Gabriel, B. Racz, V. Denes, P. Kiss, A. Lubics, I. Lengvari, and D. Reglodi Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate Neurosci. Lett. 372 2004 110 113 (Pubitemid 39505238)
47. J. Tang, and T.S. Kern Inflammation in diabetic retinopathy Prog. Retin. Eye Res. 30 5 2011 343 358
48. M. Tsutsumi, T.H. Claus, Y. Liang, Y. Li, L. Yang, J. Zhu, F. Dela Cruz, X. Peng, H. Chen, S.L. Yung, S. Hamren, J.N. Livingston, and C.Q. Pan A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes Diabetes 51 5 2002 1453 1460 (Pubitemid 34826611)
49. D. Vaudry, B.J. Gonzalez, M. Basille, T.F. Pamantung, M. Fontaine, A. Fournier, and H. Vaudry The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32 Proc. Natl. Acad. Sci. U.S.A. 97 2000 13390 13395
50. D. Vaudry, T.F. Pamantung, M. Basille, C. Rousselle, A. Fournier, H. Vaudry, J.C. Beauvillain, and B.J. Gonzalez PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis Eur. J. Neurosci. 15 2002 1451 1460 (Pubitemid 35477975)
51. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B.K. Chow, H. Hashimoto, L. Galas, and H. Vaudry Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery Pharmacol. Rev. 61 2009 283 357
52. J.A. Waschek Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration Dev. Neurosci. 24 2002 14 23 (Pubitemid 36151214)
53. H. Zhang, R. Yu, X. Liu, X. Guo, and Z. Zeng The expression of PAC1 increases in the degenerative thymus and low dose PACAP protects female mice from cyclophosphamide induced thymus atrophy Peptides 38 2012 337 343